Clinical Trials Directory

Trials / Terminated

TerminatedNCT00717639

Vasovist Magnetic Resonance Angiography (MRA) in Peripheral Arterial Occlusive Disease

Determination of Diagnostic Accuracy and Added Value of Vasovist®-Enhanced Peripheral MRA in Comparison to Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients With Peripheral Artery Disease

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Heidelberg University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims at investigating the diagnostic accuracy of magnetic resonance angiography using the contrast agent Vasovist® in the detection of relevant vascular narrowing of the lower extremity. Patients who have been scheduled for intra-arterial conventional angiography are eligible for this trial.

Detailed description

Patients will only be included into the study if either MRA with extracellular contrast agents, computed tomography angiography, ultrasound or i.a. DSA have been performed beforehand and if the patient has been scheduled for an i.a. DSA to be performed. Vasovist® enhanced MRA imaging will be performed using a state-of-the-art 1.5T MR system. Recruitment, baseline examinations, Vasovist®-enhanced MRA of the vessel segments of interest and follow-up examinations will be performed in up to 8 radiological clinics in Europe. The safety follow-up period will be at least 12 hours but not more than 24 hours post injection of Vasovist® and includes the assessment of physical examinations and vital signs as well as the assessment of AEs. DSA must be carried out at least 12 hours after Vasovist® administration and only after the last follow-up visit has been performed.

Conditions

Interventions

TypeNameDescription
PROCEDUREDiagnostic MR-AngiographySingle MR-Angiography of the lower extremity after the bolus injection 0.03mmol/kg BW Vasovist

Timeline

Start date
2008-05-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2008-07-17
Last updated
2011-08-08

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00717639. Inclusion in this directory is not an endorsement.